3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
13
Neoplasms
5
Neoplasm Metastasis
3
Triple Negative Breast Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Recurrence
2
Neoplasms by Site
2
Liposarcoma
2
Head and Neck Neoplasms
2
Endometrial Neoplasms
2
Breast Diseases
2
Brain Neoplasms
2
Uterine Cervical Neoplasms
1
Unilateral Breast Neoplasms
1
Spinal Cord Neoplasms
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Recurrent Ovarian High Grade Serous Adenocarcinoma
1
Pathologic Complete Response
1
Ovarian Neoplasms
1
Neoplasms, Squamous Cell
1
Multiple Myeloma
1
Meningioma
1
Lymphoma, Non-Hodgkin
1
Locally Advanced (Inoperable) or Metastatic Breast Cancer
1
Leiomyosarcoma
1
Hereditary Sensory and Autonomic Neuropathies
1
Hemangiosarcoma
1
HR+/HER2- Breast Cancer
1
Glioma
1
Interventions
Specimen Handling
2
Magnetic Resonance Spectroscopy
2
trastuzumab deruxtecan
1
trastuzumab biosimilar HLX02
1
taxane
1
radium Ra 223 dichloride
1
pertuzumab
1
X-Rays
1
Trastuzumab
1
Taxoids
1
Taxes
1
Steroids
1
Radiotherapy
1
Radiosurgery
1
Radiation
1
Photons
1
Paclitaxel
1
PF-05280014
1
Ontruzant
1
Ogivri
1
Mastectomy, Simple
1
Mastectomy, Segmental
1
Hormones
1
High-Energy Shock Waves
1
Cyclin-Dependent Kinase Inhibitor p18
1
Cyclin-Dependent Kinase Inhibitor p16
1
CT-P6
1
Biopsy
1
Ado-Trastuzumab Emtansine
1
2C4 antibody
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Anatomic Stage IV Breast Cancer AJCC v8
×
abemaciclib
×
30 days
×
Clear all
No trials found.